Phenylethylamine caps (PEA) (120 caps)
Manufactured by: PrimaForce
|
|
Directions:
As a dietary supplement, take 1-2 capsules daily or as directed by a health professional.
WARNING:
The recommended dose of this product contains about as much caffeine as 1 or 2 cups of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness and occasionally rapid heartbeat. For occasional use only. Not intended for use as a substitute for sleep. If fatigue or drowsiness persists or continues to occur, consult a physician. Do not use if you are diabetic. AS WITH ANY DRUG, IF YOU ARE PREGNANT OR NURSING A BABY, SEEK THE ADVICE OF A HEALTH PROFESSIONAL BEFORE USING THIS PRODUCT.
|
PrimaForce Phenylethylamine Caps
PrimaForce Phenylethylamine caps are lab tested for potency and purity. PrimaForce is committed to providing their consumers wit high-quality, research-proven products to enhance performance, body composition, and quality of life.
PEA is a naturally occurring substance found in such items as blue-green algae, salami, bologna, and of course, chocolate. In recent years, it has also become an extremely popular ingredient in numerous dietary supplements, ranging from weight loss products to ‘whole health’ products.
Often dubbed “The love molecule” PEA, is a compound naturally produced by the brain, is responsible for the feeling of experiences associated with pleasure and mental awareness. For example, when one is absorbed by an activity like painting, sculpting, or reading a fascinating book, when the world around seems suspended and nothing can disturb us, when worries vanish and hunger goes away, in such moments PEA is being produced by the brain. Likewise, PEA is released in the brain when one experiences the feelings of love and joy. For this reason, PEA has been coined “The love molecule.” When taken orally, PEA is known to readily cross the blood-brain barrier and become immediately available in the brain.
In the brain, PEA is believed to act by having a greater affinity for the re-uptake mechanism for dopamine in presynaptic vesicles. Therefore, when present in the brain, PEA is captured into the presynaptic vesicles and occupies the space normally taken by dopamine. This leads to an increase in free-circulating dopamine in the presynaptic terminal and a higher concentration of dopamine diffusing into the synaptic cleft, therefore enhancing dopaminergic transmission.
This ability to modulate dopaminergic transmission provides PEA with interesting properties in increasing concentration and elevating mood.
PEA has also been shown to enhance norepinephrine transmission in the brain. Norepinephrine is also involved in the experience of joy. Enhancing norepinephrine transmission in the brain increases the experience of joy and reduces appetite. For example, if an animal is implanted with an electrode in an area of the brain concentrated in norepinephrine, and this electrode is activated by a pedal that the animal has access to, the animal will disregard food and water and will press the pedal relentlessly until exhaustion to elicit an electrical impulse in this area of the brain.
Finally, PEA also carries another interesting benefit. As mention ed before, PEA is produced by the brain when one is fully absorbed into an activity like painting, sculpting or reading a fascinating book. At such a time, the world seems to disappear around us, and we are no longer hungry. This phenomenon is not an anorectic effect in which hunger completely disappears but happens because our attention is taken away from the feeling of hunger. In this manner, PEA acts as an appetite suppressant. Therefore, through its ability to reduce appetite, PEA is an effective supplement to be taken as part of a comprehensive weight-loss program.
Recommended dosage is 100mg daily or as directed by a physician. One should never exceed the recommended dose as results will not improve and the possibility for side effects becomes much greater. Do not use if you have high blood pressure, or any other medical or emotional condition. Do not use if you are pregnant, nursing, or may become pregnant. Do not use if you are taking any prescription drugs. Discontinue use at once and seek medical attention if side effects occur. Always consult your doctor before starting any supplement regimen.
These statements have not been evaluated by the FDA. This product is not intended to treat, diagnose, cure or prevent any disease.
Gitta S. Jensen, PhD., Donald I. Ginsberg, M.S., Christian Drapeau, M.S. Blue-Green Algae as an Immuno-Enhancer and Biomodulator JANA Winter 2001 Vol. 3 No.4: (24 - 30).
Phenylethylamine, a possible link to the feel good effects of exercise? Szabo A, Billett E, Turner J. Br J Sports Med. 2001 Oct;35(5):342-3.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11579070&dopt=Abstract
Elusive amines and primary headaches: historical background and prospectives. D'Andrea G, Terrazzino S, Fortin D, Cocco P, Balbi T, Leon A. Neurol Sci. 2003 May;24 Suppl 2:S65-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12811595&dopt=Abstract
The urinary excretion of 2-phenylethylamine in phenylketonuria.
Reynolds GP, Seakins JW, Gray DO. Clin Chim Acta. 1978 Feb 1;83(1-2):33-9.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=620466&dopt=Abstract
Increased urine phenylethylamine after methylphenidate treatment in children with ADHD . Kusaga A, Yamashita Y, Koeda T, Hiratani M, Kaneko M, Yamada S, Matsuishi T. Ann Neurol. 2002 Sep;52(3):372-4.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12205654&dopt=Abstract
Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine . Zametkin AJ, Karoum F, Linnoila M, Rapoport JL, Brown GL, Chuang LW, Wyatt RJ. Arch Gen Psychiatry. 1985 Mar;42(3):251-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2579615&dopt=Abstract
Trace amines: Identification of a family of mammalian G protein-coupled receptors Beth Borowsky, Nika Adham, Kenneth A. Jones, Rita Raddatz, Roman Artymyshyn, Kristine L. Ogozalek, Margaret M. Durkin, Parul P. Lakhlani, James A. Bonini, Sudam Pathirana, Noel Boyle, Xiaosui Pu, Evguenia Kouranova, Harvey Lichtblau, F. Yulina Ochoa, Theresa A. Branchek, and Christophe Gerald. Proc. Natl. Acad. Sci. USA. 2001 July 31; 98 (16): 8966–8971
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=11459929#B4
|
)
